Waters Acquires Blue Reference for $14M, Pays $3M to Settle IP Dispute | GenomeWeb

NEW YORK (GenomeWeb News) – Waters said in its Form 10-Q for the second quarter that it has acquired software firm Blue Reference for $14 million in cash.

In its document filed Friday with the US Securities and Exchange Commission, the company also disclosed a $3 million payment to settle litigation alleging patent infringement by Waters.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.